...
首页> 外文期刊>EFSA Journal >Vibigaba (germinated brown rice) and maintenance of long‐term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No?1924/2006
【24h】

Vibigaba (germinated brown rice) and maintenance of long‐term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No?1924/2006

机译:Vibigaba(发芽糙米)和维持长期正常血糖浓度:根据法规(EC)1924/2006第13(5)条对健康声明的评估

获取原文
           

摘要

Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and maintenance of long‐term normal blood glucose concentration. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panel considers that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is ‘contribution to the maintenance of normal glycated haemoglobin level’. The Panel considers that maintenance of long‐term normal blood glucose concentration is a beneficial physiological effect. The Panel notes that the applicant did not perform a comprehensive literature search to identify human intervention studies which could be pertinent to the claim. The applicant did not reply to a specific request from EFSA to provide this information. The applicant identified one human intervention study as being pertinent to the claim. The Panel notes the important methodological limitations of the study (e.g. statistical methods used for data analysis not appropriate for the study design) and that the information provided on the design and conduct of the study is insufficient for a complete scientific evaluation. The Panel considers that no conclusions can be drawn from this study for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship has not been established between the consumption of Vibigaba (germinated brown rice) and maintenance of long‐term normal blood glucose concentration.
机译:在Loc Troi集团提出申请后,根据1924/2006号法规(EC)第13(5)条,通过荷兰主管当局,EFSA营养产品,营养和过敏专门委员会(EFSA)提交了健康要求授权( NDA被要求就有关Vibigaba(发芽糙米)的健康主张的科学依据和维持长期正常血糖浓度发表意见。根据新近开发的科学证据,建议将应用范围归入健康声明。申请人提出的作为健康要求标的的食物是Vibigaba。小组认为,发芽的糙米Vibigaba具有充分的特征。申请人提出的要求保护的作用是“对维持正常糖化血红蛋白水平的贡献”。专家组认为,维持长期正常的血糖浓度是有益的生理作用。小组注意到,申请人没有进行全面的文献检索来确定可能与索赔有关的人为干预研究。申请人未回复EFSA提供此信息的特定要求。申请人确定一项人为干预研究与该索赔有关。专家小组注意到该研究的重要方法学局限性(例如,不适用于研究设计的用于数据分析的统计方法),并且关于研究设计和进行的信息不足以进行全面的科学评估。小组认为,就索赔的科学依据而言,无法从这项研究得出任何结论。专家组得出结论,食用比比巴巴(发芽糙米)与维持长期正常血糖浓度之间尚未建立因果关系。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号